Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group.

Literature DB >> 7799716

Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group.

M Hommel, J P Boissel, C Cornu, F Boutitie, K R Lees, G Besson, D Leys, P Amarenco, M Bogaert.

Abstract

Entities: Disease

Mesh：

Substances：
Streptokinase

Year: 1995 PMID： 7799716 DOI： 10.1016/s0140-6736(95)91179-0

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

20 in total

1. Proteomic Protease Substrate Profiling of tPA Treatment in Acute Ischemic Stroke Patients: A Step Toward Individualizing Thrombolytic Therapy at the Bedside.

Authors: Mingming Ning; David A Sarracino; Ferdinando S Buonanno; Bryan Krastins; Sherry Chou; David McMullin; Xiaoying Wang; Mary Lopez; Eng H Lo
Journal: Transl Stroke Res Date: 2010-12-01 Impact factor: 6.829

2. Hemorrhage/contrast staining areas after mechanical intra-arterial thrombectomy in acute ischemic stroke: imaging findings and clinical significance.

Authors: G Parrilla; B García-Villalba; M Espinosa de Rueda; J Zamarro; E Carrión; F Hernández-Fernández; J Martín; R Hernández-Clares; A Morales; A Moreno
Journal: AJNR Am J Neuroradiol Date: 2012-04-26 Impact factor: 3.825

3. Analysis of the National Institute of Neurological Disorders and Stroke tissue plasminogen activator studies following European Cooperative Acute Stroke Study III patient selection criteria.

Authors: Thomas M Hemmen; Karen S Rapp; Jennifer A Emond; Rema Raman; Patrick D Lyden
Journal: J Stroke Cerebrovasc Dis Date: 2010-05-14 Impact factor: 2.136

Review 10. Alteplase. A reappraisal of its pharmacology and therapeutic use in vascular disorders other than acute myocardial infarction.

Authors: A J Wagstaff; J C Gillis; K L Goa
Journal: Drugs Date: 1995-08 Impact factor: 9.546

Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group.

1. Proteomic Protease Substrate Profiling of tPA Treatment in Acute Ischemic Stroke Patients: A Step Toward Individualizing Thrombolytic Therapy at the Bedside.

2. Hemorrhage/contrast staining areas after mechanical intra-arterial thrombectomy in acute ischemic stroke: imaging findings and clinical significance.

3. Analysis of the National Institute of Neurological Disorders and Stroke tissue plasminogen activator studies following European Cooperative Acute Stroke Study III patient selection criteria.

4. Thrombolysis in acute stroke.

Review 5. Thrombolytic therapy for stroke: a review with particular reference to elderly patients.

6. Treating acute ischaemic stroke.

Review 7. Drug treatment of acute ischemic stroke.

Review 8. Plasminogen activators and ischemic stroke: conditions for acute delivery.

Review 9. Pharmaco-proteomics opportunities for individualizing neurovascular treatment.

Review 10. Alteplase. A reappraisal of its pharmacology and therapeutic use in vascular disorders other than acute myocardial infarction.